GT Biopharma
GTBP
GTBP
53 hedge funds and large institutions have $16.7M invested in GT Biopharma in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 6 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 11
48% less capital invested
Capital invested by funds: $32.1M → $16.7M (-$15.4M)
Holders
53
Holding in Top 10
–
Calls
$334K
Puts
$239K
Top Buyers
| 1 | +$741K | |
| 2 | +$677K | |
| 3 | +$581K | |
| 4 |
Two Sigma Advisers
New York
|
+$210K |
| 5 |
State Street
Boston,
Massachusetts
|
+$167K |
Top Sellers
| 1 | -$708K | |
| 2 | -$254K | |
| 3 | -$230K | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$227K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$150K |